Topics

Videos

In an interview with  Pharma Commerce editor Nicholas Saraceno, Bill Roth, General Manager, Managing Partner, Blue Fin Group, discusses changes that will come with the pharma giant's new platform.

The Impact of Eli Lilly's New DTC Platform on Rx Drug Sales and Patient Access: An Interview with Bill Roth, General Manager, Managing Partner, Blue Fin Group

Articles

EdenHelp is expected to provide HCPs and patients with real-time access to Rx drug and medical device information. 

 P360 Builds Out New Artificial Intelligence-Powered Platform

The group—known as the Innovators' Network—is meant to serve as a link between entrepreneurs, providers, researchers, and payers while they strive to combat cardiovascular disease.

ixlayer Becomes Member of American Heart Association Center for Health Technology & Innovation Consortium 

While often portrayed in a negative light, it is important to find a balanced perspective on its role in the pharma sector. 

A Closer Look at PBM Spread Pricing

Study examines the parallels between doctorate students and the US population.

Diversity Trends in Health Professions Programs 

How pharma companies can be successful in financial forecasting, including why these forecasts should be powered by a patient-based approach.

Strategic Insight and Forecasting: From Pipeline to Pharmacy

In the face of chronic disease, DTx have the opportunity to provide a lifeline to patients. 

How Healthcare Economics Outcomes Evidence Can Pave the Way for Digital Therapeutics

Breakout session summarizes key areas that will affect all aspects of the industry. 

Trade & Channel Strategies 2023: IRA—All the Things Beyond Price Negotiations That Will Impact Your Business

Bayer executive talks Enable Holistic Hub and Provider Services panel.

Trade & Channel Strategies 2023: An Interview with Bayer's Spencer Miller

Session discusses ways to integrate digital pharmacies and hubs.

Patient Support